Tally Of Drug Makers Imposing 340B Restrictions Rises To 21

Two more drug companies -- Germany-based Bayer HealthCare Pharmaceuticals and EMD Serono, a subsidiary of Germany-based Merck KGaA -- have announced they will restrict the number of contract pharmacies hospitals and clinics can use to dispense discounted drugs under the 340B program. The new policies are expected to go into effect March 1, making the companies the 20th and 21st drug makers to impose such restrictions since 2020. The announcements come just after the Third Circuit Court of Appeals ruled...